000 | 01864 a2200505 4500 | ||
---|---|---|---|
005 | 20250516034813.0 | ||
264 | 0 | _c20120516 | |
008 | 201205s 0 0 eng d | ||
022 | _a1573-2584 | ||
024 | 7 |
_a10.1007/s11255-011-9980-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEkici, Sinan | |
245 | 0 | 0 |
_aFluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment. _h[electronic resource] |
260 |
_bInternational urology and nephrology _cFeb 2012 |
||
300 |
_a19-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntibiotic Prophylaxis _xadverse effects |
650 | 0 | 4 |
_aBiopsy _xadverse effects |
650 | 0 | 4 |
_aCarbapenems _xtherapeutic use |
650 | 0 | 4 |
_aCeftriaxone _xtherapeutic use |
650 | 0 | 4 |
_aCiprofloxacin _xtherapeutic use |
650 | 0 | 4 | _aDrug Resistance, Multiple, Bacterial |
650 | 0 | 4 | _aEnterococcus |
650 | 0 | 4 | _aEscherichia coli |
650 | 0 | 4 |
_aEscherichia coli Infections _xdrug therapy |
650 | 0 | 4 |
_aFluoroquinolones _xtherapeutic use |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLength of Stay |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aProstate _xpathology |
650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
650 | 0 | 4 |
_aProstatitis _xblood |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aVancomycin _xtherapeutic use |
700 | 1 | _aCengiz, Melahat | |
700 | 1 | _aTuran, Güven | |
700 | 1 | _aAlış, Esra Ergün | |
773 | 0 |
_tInternational urology and nephrology _gvol. 44 _gno. 1 _gp. 19-27 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11255-011-9980-3 _zAvailable from publisher's website |
999 |
_c20811119 _d20811119 |